Fosfomycin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Fosfomycin and local guidelines before prescribing.
Phosphonic acid antibiotic
Mechanism
Inhibits bacterial cell-wall synthesis (MurA).
Uses
Uncomplicated lower UTI (single dose), resistant infections (IV).
Dosing
- Second line: Pivmecillinam or fosfomycin (3 g single dose).
Renal: Tubular Inherited Stones - Fosfomycin 3 g single dose | Second-line lower UTI in women.
Renal: Tubular Inherited Stones - Fosfomycin - single 3 g oral dose for uncomplicated lower UTI in women (including some ESBL); IV for specialist use.
ID: How Infection Happens
Side effects
Diarrhoea, headache, nausea.
Interactions
Metoclopramide reduces levels.
Contraindications and cautions
Severe renal impairment
Monitoring
Symptoms
Pregnancy and breastfeeding
Acceptable
Renal and hepatic impairment
Avoid if CrCl below 10
Overdose and reversal
Supportive
Special advice
Single 3 g sachet for cystitis in women.
More from the textbook: uses, cautions and other points
- Second-line - pivmecillinam or fosfomycin (single dose).
Renal: Anatomy, Physiology and Pharmacology - Use pivmecillinam or fosfomycin (per local guidance and urine culture); check FBC if there are signs of methotrexate toxicity.
Renal: Anatomy, Physiology and Pharmacology - ESBL-producing Gram-negatives (E. coli, Klebsiella) - resistant to most penicillins and cephalosporins; serious infections need a carbapenem (or other options by sensitivity); oral options for UTI may include nitrofurantoin, fosfomycin, pivmecillinam.
ID: How Infection Happens - Treatment - serious infections usually need a carbapenem (meropenem or ertapenem); alternatives by sensitivity (piperacillin–tazobactam sometimes, temocillin, aminoglycosides); oral options for UTI - nitrofurantoin, fosfomycin, pivmecillinam.
ID: Hospital infection, the immunocompromised host, vaccination and public health - Escherichia coli - commonest cause of UTI and Gram-negative bacteraemia ; neonatal meningitis (K1 capsule), intra-abdominal infection, travellers' diarrhoea (ETEC), STEC O157 (HUS). ESBL-producing E. coli and Klebsiella are resistant to cephalosporins - carbapenems, or nitrofurantoin/fosfomycin/pivmecillinam for lower UTI per …
Microbiology: Bacteriology - structure, classification and important pathogens - Other | Nitrofurantoin, fosfomycin, pivmecillinam | - | Lower UTI only (urinary concentration)
Microbiology: Diagnostic microbiology, antimicrobials and resistance
Where it is discussed in the book
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Tubular Inherited Stones (2 mentions)
- ID: How Infection Happens (2 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (1 mention)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)
- Microbiology: Diagnostic microbiology, antimicrobials and resistance (1 mention)